web statistics
PRESS ROOM        PUBLICATIONS       CAREERS
Investor Relations & News
KineMed  ► Investor Relations & News > Press Room > KineMed Receives U.S. Patent Allowance for Noscapine to Treat ALS, Parkinson’s Disease, and Diabetic

Forthcoming Events

Latest News

KineMed Receives U.S. Patent Allowance for Noscapine to Treat ALS, Parkinson’s Disease, and Diabetic Neuropathy

KineMed Receives U.S. Patent Allowance for Noscapine to Treat ALS, Parkinson’s Disease, and Diabetic Neuropathy

Videos & Webcasts


www.kinemed.com

 Copyright © 2014 KineMed, Inc.  |  All Rights Reserved  |  Privacy  |  Terms & Conditions